Clinuvel PharmaceuticalsCUV 
$9.82-0.67%24h
-0.67%24h
Global rank11479
Market cap$485.22M
Change 7d-5.64%
YTD Performance-8.06%
SP500 benchmarkUnderperform
P/E16.62
P/S9.29
Revenue$52.25M
Earnings$20.42M
Dividend yield-
Main Sector
Healthcare
Category
Clinuvel Pharmaceuticals (CUV) Total Liabilities
CUV Total Liabilities in 2022: $19.40M
According to Clinuvel Pharmaceuticals latest financial reports the total liabilities of CUV is $19.40M, an increase of 58.14% to 2022. At the end of 2022 company had $12.27M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Clinuvel Pharmaceuticals is responsible for during its operational activities.
Clinuvel Pharmaceuticals (CUV) Total Liabilities History from 2023 to 2022
-
Value:-
CUV Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $19.40M | 58.14% |
| 2022 | $12.27M | 87.08% |
| 2021 | $6.56M | 24.85% |
| 2020 | $5.25M | 307.37% |
| 2019 | $1.29M | - |
View the Top Total Liabilies Stocks
